Thank you very much, Madam Chair.
I too want to welcome you here. It's always a pleasure to have you appear before the committee. I think your briefings to us are always full of excellent information.
I want to go back to a comment my colleague made about the anti-CCSVI campaign that's taken place, in her estimation. Certainly I would take some umbrage to a comment like that, because I think those of us who are questioning this therapy are doing it because we haven't precluded the outcome. We are willing to allow the researchers to do the work they need to do in order to ensure that this is evidence-based.
The Canadian Medical Association wrote a letter supporting the position that the majority of our members took yesterday on this issue. Could you explain why the CMA supports our position? Have you had that conversation?